The Sahajanand Medical Technologies IPO is witnessing steady investor momentum across its second day of active bidding in the IPO market today as Sahajanand Medical Technologies Ltd commands firm retail and HNI bids on the BSE and NSE mainboards. Positioned as a flagship indigenous healthcare technology issue among the latest Mainboard IPO offerings, the public issue brings India’s largest domestic cardiovascular medical device innovator to public bourses. In this book-built offer, Sahajanand Medical Technologies is raising ₹475.48 crore via a 100% Offer for Sale (OFS) of 1.38 crore equity shares at a Mainboard IPO issue price band of ₹327 to ₹344 per share. Tracking IPO updates today, retail allocators and institutional asset managers are closely monitoring Day 2 order book velocity for the Sahajanand Medical Technologies IPO.
What the Grey Market Is Signaling
Unlisted dealing desks tracking the IPO grey market today reflect consistent and positive sentiment for the Sahajanand Medical Technologies IPO. The Sahajanand Medical Technologies IPO GMP live is trading firmly at +₹44 to +₹48 per share over the upper price band of ₹344. Evaluating the Mainboard IPO GMP today, the expected IPO listing gain for the Sahajanand Medical Technologies IPO is projected between 12.79% and 13.95%, pointing to an indicative listing print near ₹388 to ₹392. Rather than volatile speculative froth, this steady IPO grey market premium indicates that market participants across latest IPO GMP channels are pricing in the defensible cardiovascular moat of Sahajanand Medical Technologies Ltd as global supply chains diversify toward specialized medical equipment manufacturers.
Subscription Numbers Back the Hype: Day 2 Live Demand
Heading into the final stretch of Day 2 bidding, syndicate desks report healthy traction across the Sahajanand Medical Technologies IPO order books:
- Net Offer Allocation: Out of the net public offer for Sahajanand Medical Technologies, not more than 50% is reserved for Qualified Institutional Buyers (QIBs), not less than 15% for Non-Institutional Investors (NIIs), and not less than 35% for Retail Individual Investors.
- Retail Lot Commitment: A single retail application for the Sahajanand Medical Technologies IPO requires a minimum lot size of 43 shares, amounting to an accessible capital outlay of ₹14,792 at the cut-off price.
- Day 2 Bidding Velocity: Exchange order books reflect steady accumulation, with retail individual investors bidding their quota up to 0.86x and NIIs clocking 0.68x, while institutional QIB books in the Sahajanand Medical Technologies IPO are laying the groundwork for substantial deployment on the final day.
Why the Market Is Bullish on This Mainboard IPO
Key operational moats highlighted in the Sahajanand Medical Technologies Mainboard IPO details include:
- Cardiovascular Stent & TAVI Moat: Sahajanand Medical Technologies commands approximately 25% domestic market share by sales volume in the drug-eluting stent (DES) segment, alongside an expanding presence in structural heart therapies such as Transcatheter Aortic Valve Implantation (TAVI).
- Global Footprint & Specialized Manufacturing: Sahajanand Medical Technologies Ltd distributes advanced vascular devices across 77 countries, backed by three specialized manufacturing hubs in Surat, Hyderabad, and Thailand, alongside dedicated medical research facilities.
- Operational Turnaround & Compounding: For FY26, consolidated revenues for Sahajanand Medical Technologies surpassed ₹1,210 crore, with operating EBITDA scaling to ₹170.65 crore, marking a positive operational turnaround and sustained margin expansion.
- Defensible Intellectual Property: Holding over 119 granted patents across international jurisdictions, Sahajanand Medical Technologies Ltd commands a post-issue market capitalization of ₹3,496.65 crore at the upper band, pricing the business at an attractive multiple compared to global med-tech peers.
Important Caveats for Grey Market Watchers
Before tracking the Sahajanand Medical Technologies Mainboard IPO GMP, keep these risk factors in view:
- 100% OFS Structure: The offering is entirely an Offer for Sale of 1.38 crore shares; Sahajanand Medical Technologies Ltd receives zero fresh capital on its corporate balance sheet from the Sahajanand Medical Technologies IPO.
- Raw Material & Component Dependency: The production operations of Sahajanand Medical Technologies depend on specialized international component suppliers for biocompatible alloys and delivery catheters without long-term supply agreements.
- Price Discovery: Final listing gains for Sahajanand Medical Technologies depend strictly on official exchange order matching when the stock debuts on the Mainboard IPO list.
The Bottom Line: Mainboard IPO Listing Date & Schedule
The Sahajanand Medical Technologies IPO offers investors direct exposure to a research-driven, high-barrier medical technology enterprise with significant global export integration. With the Mainboard IPO GMP today indicating positive opening sentiment, primary market desks are tracking the scheduled timetable for the Sahajanand Medical Technologies IPO:
- Public Bidding Closes: Monday, October 19, 2026 (5:00 PM UPI cutoff)
- Basis of Allotment: Wednesday, October 21, 2026, for the Sahajanand Medical Technologies IPO, verifiable via MUFG Intime India Pvt. Ltd.
- Refund Initiation & Demat Credit: Thursday, October 22, 2026
- Mainboard IPO Listing Date: Friday, October 23, 2026, on BSE and NSE for Sahajanand Medical Technologies